Okazepine tablets - Approved for Marketing
The national essential medicine and the medical insurance category A drug, Oxcarbazepine Tablets, has been approved for market release.
Gabapentin capsules - Approved for Marketing
The anti-epileptic drug - Gabapentin Capsules, which is classified as a category B drug in medical insurance, has been approved for market release.
Dapoxetine Hydrochloride Tablets - Approved for Marketing
The dapoxetine hydrochloride tablets have been approved under the new classification for chemical drugs.
Atenolol tablets - Approved for Marketing
National essential drugs, Class A drugs covered by medical insurance
Fluvoxamine Maleate Tablets - Approved for Marketing
The "Five Star Drugs" of Antidepressants
Ebastine tablets - Approved for Marketing
Anti-allergy "star product"